Ferozsons established the pharmaceuticals plant in the year 1956 where production first commenced for several life-saving medicines. With patient-centricity at the core of our operations, the pharmaceuticals manufacturing division created a number of alliances with leading global companies to bring the most needed treatments to Pakistan.

The pharmaceuticals division is the largest in Ferozsons Laboratories Limited producing high quality generics as well as maintaining exclusive partnerships with a number of international partners for distribution, marketing and co-manufacturing of products under technology transfer arrangements including the Latin American biopharmaceutical leader Bagó Group of Argentina, probiotics pioneer BioGaia of Sweden, Performance Health for BioFreeze line of leading topical analgesic products, with upcoming PanTheryx for breakthrough anti-diarrheal products as well as our biggest collaboration to date with the leading innovative biopharmaceutical company, Gilead Sciences, Inc. of the USA that has revolutionized the treatment of Hepatitis C.

Ferozsons possesses leadership brands in the areas of gastroenterology, hepatology, cardiology and oncology, with an emerging presence in endocrinology as well as mother and child health. As the largest department of the organization, our team of 600+ members is spread across the entire country and is actively engaged with our customers in key therapeutic areas that we serve. Our portfolio carries leading brands in high quality generics as well as imported medicines that cater to the most needed treatments in the local market.